单位(元)招商国证生物医药指数A(161726)资产负债表 |
| 报告期 |
2025/6/30 |
2024/12/31 |
2024/6/30 |
2023/12/31 |
| 资产 |
| 银行存款 |
494,087,408 |
360,762,059 |
221,014,802 |
258,695,990 |
| 结算备付金 |
56 |
1,437,014 |
1,657,131 |
5,240,475 |
| 存出保证金 |
363,520 |
519,461 |
328,678 |
388,815 |
| 交易性金融资产 |
8,718,812,255 |
9,483,925,432 |
9,171,151,213 |
12,324,714,667 |
| 其中：股票投资 |
8,701,038,424 |
9,274,061,334 |
8,842,370,318 |
11,898,027,051 |
| 基金投资 |
- |
- |
- |
- |
| 债券投资 |
17,773,831 |
209,864,099 |
328,780,895 |
426,687,616 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
31,332 |
- |
- |
155,068 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
8,071,830 |
18,611,632 |
16,670,530 |
27,828,413 |
| 其他资产 |
- |
- |
19,755 |
150,131 |
| 资产总计 |
9,221,366,401 |
9,865,255,598 |
9,410,842,108 |
12,617,173,558 |
| 负债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
- |
9,817,157 |
- |
| 应付赎回款 |
34,399,795 |
40,975,482 |
32,840,272 |
37,979,814 |
| 应付管理人报酬 |
7,575,096 |
8,780,805 |
7,991,166 |
10,691,072 |
| 应付托管费 |
1,515,019 |
1,756,161 |
1,598,233 |
2,138,214 |
| 应付销售服务费 |
137,592 |
173,487 |
152,998 |
176,263 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
412 |
4,210 |
16,226 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
745,160 |
2,327,897 |
2,491,312 |
2,955,679 |
| 负债合计 |
44,372,662 |
54,014,245 |
54,895,347 |
53,957,267 |
| 所有者权益 |
| 实收基金 |
16,691,273,020 |
18,374,975,675 |
18,609,163,779 |
17,829,965,084 |
| 未分配利润 |
-7,514,279,281 |
-8,563,734,322 |
-9,253,217,017 |
-5,266,748,793 |
| 所有者权益合计 |
9,176,993,739 |
9,811,241,352 |
9,355,946,762 |
12,563,216,291 |
| 负债和所有者权益总计 |
9,221,366,401 |
9,865,255,598 |
9,410,842,108 |
12,617,173,558 |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
